{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:49:28Z","timestamp":1777693768927,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T00:00:00Z","timestamp":1340064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1208\/s12248-012-9380-3","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T16:47:38Z","timestamp":1340038058000},"page":"657-663","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of an Innovative Population Pharmacokinetic-Based Design for Behavioral Pharmacodynamic Endpoints"],"prefix":"10.1208","volume":"14","author":[{"given":"Anders","family":"Viberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M. A.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,19]]},"reference":[{"issue":"3","key":"9380_CR1","first-page":"8","volume":"47","author":"OI Abatan","year":"2008","unstructured":"Abatan OI, Welch KB, Nemzek JA. Evaluation of saphenous venipuncture and modified tail-clip blood collection in mice. J Am Assoc Lab Anim Sci. 2008;47(3):8\u201315.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"9380_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bbr.2009.07.005","volume":"205","author":"L Bardin","year":"2009","unstructured":"Bardin L, Malfetes N, Newman-Tancredi A, Depoortere R. Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: relevance to human stress-associated painful pathologies. Behav Brain Res. 2009;205:360\u20136.","journal-title":"Behav Brain Res"},{"issue":"4","key":"9380_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ilar.43.4.194","volume":"43","author":"BR Howard","year":"2002","unstructured":"Howard BR. Experimental design and statistics in biomedical research. ILAR J. 2002;43(4):194\u2013201.","journal-title":"ILAR J"},{"key":"9380_CR4","first-page":"1","volume":"2011","author":"F Huang","year":"2010","unstructured":"Huang F, Zhang M, Chen Y-J, Li Q, Wu A-Z. Psychological stress induces temporary mastictory muscle mechanical sensitivity in rats. J Biomed Biotechnol. 2010;2011:1\u20138.","journal-title":"J Biomed Biotechnol"},{"key":"9380_CR5","doi-asserted-by":"publisher","first-page":"E823","DOI":"10.1152\/ajpendo.00122.2005","volume":"289","author":"PV Torsten","year":"2005","unstructured":"Torsten PV, Ulrich-Lai YM, Ostrander MM, Dolgas CM, Elfers EE, Seeley RJ, D\u2019Alessio DA, Herman JP. Comparative analysis of ACTH and corticosterone sampling methods in rat. Am J Physiol Endocrinol Metab. 2005;289:E823\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9380_CR6","volume-title":"The principles of humane experimental technique","author":"WMS Russell","year":"1959","unstructured":"Russell WMS, Burch RL. The principles of humane experimental technique. London: Methuen; 1959."},{"key":"9380_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1476-5381.1992.tb14213.x","volume":"105","author":"A Bartolini","year":"1992","unstructured":"Bartolini A, Ghelardini C, Fanetti L, Malcangio M, Malmberg-Aiello P, Giotti A. Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol. 1992;105:77\u201382.","journal-title":"Br J Pharmacol"},{"key":"9380_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1023\/A:1022844517200","volume":"28","author":"FP Bystander","year":"2003","unstructured":"Bystander FP, McKinzie DL, Felder CC, Wess J. Use of M1\u2013M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem Res. 2003;28:437\u201342.","journal-title":"Neurochem Res"},{"key":"9380_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1124\/mol.62.5.1084","volume":"62","author":"A Duttaroy","year":"2002","unstructured":"Duttaroy A, Gomeza J, Gan J-W, Siddiqui N, Basile AS, Harman D, Smith PL, Felder CC, Levey AI, Wess J. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol. 2002;62:1084\u201393.","journal-title":"Mol Pharmacol"},{"key":"9380_CR10","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/sj.bjp.0703268","volume":"129","author":"C Ghelardini","year":"2000","unstructured":"Ghelardini C, Galeotti N, Bartolini A. Loss of muscarinic antinociception by antisense inhibition of M1 receptors. Br J Pharmacol. 2000;129:1633\u201340.","journal-title":"Br J Pharmacol"},{"key":"9380_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0014-827X(01)01091-6","volume":"56","author":"C Ghelardini","year":"2001","unstructured":"Ghelardini C, Galeotti N, Lelli C, Bartolini A. M1 receptors activation is a requirement for arecoline analgesia. Il Farmaco. 2001;56:383\u20135.","journal-title":"Il Farmaco"},{"key":"9380_CR12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0361-9230(99)00266-X","volume":"51","author":"AP Guimaraes","year":"2000","unstructured":"Guimaraes AP, Guimaraes FS, Prado WA. Modulation of carbachol-induced antinociception from the rat periaqueductal gray. Brain Res. 2000;51:471\u20138.","journal-title":"Brain Res"},{"issue":"1\u20133","key":"9380_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2008.12.044","volume":"605","author":"JN Heinrich","year":"2009","unstructured":"Heinrich JN, Butera JA, Carrick T, Kramer A, Kowal D, Lock T, Marquis K, Pausch MH, Popiolek M, Sun R, Tseng E, Uveges A, Mayer SC. Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists. Eur J Pharmacol. 2009;605(1\u20133):53\u20136.","journal-title":"Eur J Pharmacol"},{"key":"9380_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nucmedbio.2006.11.002","volume":"34","author":"DO Kiesewetter","year":"2007","unstructured":"Kiesewetter DO, Jagoda EM, Shimoji K, Ma Y, Eckelman WC. Evaluation of [18F]fluoroxanomeline 5-{4-[(6-[18F]fluorohexyl)oxy]-1,2,5-thiadiazol-3-yl}-1-methyl-1,2,3,6-tetrahydropyridine in muscarinic knockout mice. Nucl Med Biol. 2007;34:141\u201352.","journal-title":"Nucl Med Biol"},{"key":"9380_CR15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1213\/00000539-199710000-00025","volume":"85","author":"M Naguib","year":"1997","unstructured":"Naguib M, Yaksh TL. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg. 1997;85:847\u201353.","journal-title":"Anesth Analg"},{"key":"9380_CR16","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1124\/jpet.106.118604","volume":"322","author":"NR Sullivan","year":"2007","unstructured":"Sullivan NR, Leventhal L, Harrison J, Smith VA, Cummons TA, Spangler TB, Sun S-C, Lu P, Uveges AJ, Strassle BW, Piesla MJ, Ramdass R, Barry A, Schantz J, Adams W, Whiteside GT, Adedoyin A, Jones PG. Pharmacological characterization of the muscarinic agonist (3R,4R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo[2.2.1]heptane (WAY-132983) in in vitro and in vivo models of chronic pain. J Pharmacol Exp Ther. 2007;322:1294\u2013304.","journal-title":"J Pharmacol Exp Ther"},{"key":"9380_CR17","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0024-3205(03)00082-1","volume":"72","author":"J Wess","year":"2003","unstructured":"Wess J, Duttaroy A, Gomeza J, Zhang W, Yamada M, Felder CC, Bernardini N, Reeh PW. Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarninc receptor knockout mice: a review. Life Sci. 2003;72:2047\u201354.","journal-title":"Life Sci"},{"key":"9380_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrd2379","volume":"6","author":"J Wess","year":"2007","unstructured":"Wess J, Eglen RM, Gautam D. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev. 2007;6:721\u201333.","journal-title":"Nat Rev"},{"key":"9380_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.pharmtox.44.101802.121622","volume":"44","author":"J Wess","year":"2004","unstructured":"Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol. 2004;44:423\u201350.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9380_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0165-6147(03)00195-0","volume":"24","author":"J Wess","year":"2003","unstructured":"Wess J. Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol Sci. 2003;24:414\u20139.","journal-title":"Trends Pharmacol Sci."},{"issue":"3","key":"9380_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","volume":"50","author":"SH Kim","year":"1992","unstructured":"Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992;50(3):355\u201363.","journal-title":"Pain"},{"issue":"3","key":"9380_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1023\/A:1011527125570","volume":"28","author":"U W\u00e4hlby","year":"2001","unstructured":"W\u00e4hlby U, Jonsson EN, Karlsson MO. Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn. 2001;28(3):231\u201352.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"9380_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlsson MO. Xpose\u2014an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed. 1999;58(1):51\u201364.","journal-title":"Comput Methods Programs Biomed"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9380-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-012-9380-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9380-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9380-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:47:53Z","timestamp":1559605673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-012-9380-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,19]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9380"],"URL":"https:\/\/doi.org\/10.1208\/s12248-012-9380-3","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,19]]}}}